Edoxaban and Eplerenone drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Edoxaban (edoxaban) and Eplerenone (eplerenone). Common drug interactions include atrial fibrillation among females and atrial fibrillation among males.

The phase IV clinical study analyzes what interactions people have when they take Edoxaban and Eplerenone. It is created by eHealthMe based on reports of 74 people who take the same drugs from the FDA, and is updated regularly.

What is Edoxaban?

Edoxaban has active ingredients of edoxaban. eHealthMe is studying from 1,783 Edoxaban users. Check the latest studies of Edoxaban.

What is Eplerenone?

Eplerenone has active ingredients of eplerenone. It is often used in high blood pressure. eHealthMe is studying from 9,979 Eplerenone users. Check the latest studies of Eplerenone.



On Jul, 09, 2026

74 people who take Edoxaban and Eplerenone together, and have interactions are studied.

Edoxaban and Eplerenone drug interactions.

What are the common drug interactions of Edoxaban and Eplerenone, by gender? *:

female:

  1. Atrial fibrillation (fibrillation of the muscles of the atria of the heart)
  2. Hyperkalaemia (damage to or disease of the kidney)
  3. Arrhythmia (irregular heartbeat)
  4. Anaemia (lack of blood)
  5. Cardiac disorder
  6. Chest pain
  7. Dizziness
  8. Electrocardiogram st segment elevation
  9. General physical health deterioration (weak health status)
  10. Myocardial ischaemia (the blood flow through one or more of the blood vessels that lead to heart (coronary arteries) is decreased)

male:

  1. Atrial fibrillation (fibrillation of the muscles of the atria of the heart)
  2. Ileus (a painful obstruction of the ileum or other part of the intestine)
  3. Colorectal cancer (colon cancer or bowel cancer)
  4. Dysuria (painful or difficult urination)
  5. Penile pain
  6. Urinary tract obstruction
  7. Vomiting
  8. Benign prostatic hyperplasia (benign enlargement of the prostate)
  9. Dyspnoea (difficult or laboured respiration)
  10. Helicobacter infection (helicobacter pylori (h. pylori) infects stomach)

What are the common drug interactions of Edoxaban and Eplerenone, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

n/a

50-59:

n/a

60+:

  1. Atrial fibrillation (fibrillation of the muscles of the atria of the heart)
  2. Ileus (a painful obstruction of the ileum or other part of the intestine)
  3. Dysuria (painful or difficult urination)
  4. Penile pain
  5. Pollakiuria (abnormally frequent passage of relatively small quantities or urine)
  6. Urinary tract obstruction
  7. Vomiting
  8. Benign prostatic hyperplasia (benign enlargement of the prostate)
  9. Dyspnoea (difficult or laboured respiration)
  10. Helicobacter infection (helicobacter pylori (h. pylori) infects stomach)

What are the existing conditions these people have? *

  1. Atrial Fibrillation/flutter (atrial fibrillation and flutter are abnormal heart rhythms in which the atria, or upper chambers of the heart, are out of sync with the ventricles): 28 people, 37.84%
  2. Cardiac Failure: 24 people, 32.43%
  3. High Blood Cholesterol: 20 people, 27.03%
  4. Hypothyroidism (abnormally low activity of the thyroid gland, resulting in retardation of growth and mental development): 19 people, 25.68%
  5. Gout (uric acid crystals building up in the body): 19 people, 25.68%
  6. Diarrhea: 19 people, 25.68%
  7. Coronary Heart Disease (narrowing or blockage of the coronary arteries): 19 people, 25.68%
  8. Multiple Myeloma (cancer of the plasma cells): 18 people, 24.32%
  9. Atherosclerosis (disorder of the arteries): 17 people, 22.97%
  10. Arteriosclerosis Coronary Artery (thickening and hardening of arteries- coronary artery): 17 people, 22.97%

* Approximation only. Some reports may have incomplete information.

Do you take Edoxaban and Eplerenone?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Edoxaban and Eplerenone:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Edoxaban:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Eplerenone:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Edoxaban and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Eplerenone and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on edoxaban and eplerenone (the active ingredients of Edoxaban and Eplerenone, respectively), and Edoxaban and Eplerenone (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: